XENON PHARMACEUTICALS INC. (XENE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading XENE…

XENON PHARMACEUTICALS INC. (XENE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

XENON PHARMACEUTICALS INC.

XENE · CIK 1582313

4 · Oct 16, 2026 · Chief Financial Officer Kelly Thomas Patrick exercised options for 15K shares

4

Chief Financial Officer Kelly Thomas Patrick exercised options for 15K shares

Filed: Oct 16, 2026
Period: Oct 15, 2026
Accession: 0001193125-26-424428
Filer: Xenon Pharmaceuticals Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov